For instance, studies have shown that plasma levels of lncRNA BACE1 were significantly high in AD patients as compared to healthy controls and this increased plasma expression level lncRNA BACE1 levels is positively correlated with severity of cognitive deficits in AD patients [20,62]. The gene discussed is BACE1; the disease is Cognitive impairment.